source
- Cyllene Therapeutics raises €33 million to pursue HSV-based gene therapy after Krystal modelCyllene Therapeutics, a French-US biotech, announced it has secured €33 million in financing. The capital will be used to develop HSV-based gene therapy programs, aiming to replicate the approach…
- Vertex to acquire Crinetics in $10 billion deal to expand endocrinology portfolioVertex Pharmaceuticals announced it will acquire Crinetics Pharmaceuticals for $10 billion, the largest purchase in the company's history. The transaction is aimed at broadening Vertex's commercia…